In B-ALL, IL-7Rα expression is directly correlated with central nervous system (CNS) involvement at diagnosis, and the treatment of PDX models with a commercially available mouse antibody targeting IL-7Rα was able to substantially reduce leukemic cell infiltration in the CNS and prolong survival [141]. This evidence concerns the gene IL7R and precursor B-cell acute lymphoblastic leukemia.